• MGI Announces First Customer For MGISEQ-T7, Complete Genomics Accuracy Tech

    Bio-IT World News Brief | At the J.P. Morgan Healthcare Conference this week, MGI, a subsidiary of global genomics leader BGI Group, announced its first early access customer for the MGISEQ-T7, announced an MGI global sequencer user program, and updated numbers for the product install base. The company released a statement summarizing the presentation.

    Jan 11, 2019

  • The Scope Of Scrutiny

    Bio-IT World Contributed Commentary | As biotechnology, pharmaceutical, and medical device companies pursue treatment innovations to improve patient outcomes across diagnoses, many miss a significant step that has been fundamental in financial services and insurance: financial compliance risk management.

    Jan 11, 2019

  • 23andMe Will Add Weight-Loss Advice To Its DNA-Testing Services

    Bloomberg | Consumer DNA-testing giant 23andMe plans to add new wellness offerings it hopes will help its customers shed a few pounds, but some genetics experts say the jury is still out on the science behind the products.

    Jan 9, 2019

  • Igneous Brings Structure To Unstructured Data With As-A-Service Solution

    Bio-IT World | Igneous is offering its cloud-native solution to data-centric organizations in order to both monitor large amounts of data and prevent silos within the clinical research space.

    Jan 9, 2019

  • Eli Lilly Makes An $8B Cancer Genetics Bet With Loxo Acquisition

    Xconomy | Eli Lilly is set to acquire Loxo Oncology for approximately $8 billion---a deal that brings to the Indianapolis pharmaceutical giant a class of drugs that treat cancers with particular genetic signatures.

    Jan 7, 2019

  • 10x Genomics Announces $35m Funding

    Bio-IT World News Brief | On day one of the JP Morgan Healthcare Conference, 10x Genomics announces $35 million in funding as an extension of its Series D financing.

    Jan 7, 2019

  • Bristol-Myers Squibb Will Acquire Celgene In Blockbuster $74B Deal

    STAT | The transaction between biopharma giants joins two of the largest companies in oncology, both of which have been facing setbacks.

    Jan 3, 2019

  • Top 10 Stories Of 2018: Data Science, Five Use Cases For AI And Machine Learning, And More

    Bio-IT World | As we head into 2019, we at Bio-IT World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2018.

    Jan 2, 2019

  • Poll Americans Support Gene-Editing Embryos To Prevent Diseases

    STAT | Most Americans say it would be OK to use gene-editing technology to create babies protected against a variety of diseases - but a new poll shows they'd draw the line at changing DNA so children are born smarter, faster or taller.

    Dec 28, 2018

  • AI In The Clinic: What AI Will Look Like For Healthcare

    Bio-IT World | Artificial Intelligence will have as transformational an impact as the internet did, predicts Jay Bellissimo, managing partner at IBM services. Every company needs an AI strategy, he says, and it is not a problem only for IT. Data creates insight, and insight creates knowledge. Mining the 80% of the data that’s not searchable via the internet is your company’s data advantage.

    Dec 21, 2018

  • PetaGene Announces $2.1M To Further Genomic Compression

    Bio-IT World News Brief  PetaGene, a two-time winner of Bio-IT World’s Best of Show award for product excellence, has announced $2.1 million in new funding.

    Dec 20, 2018

  • Biogen, DDN, Qlucore, And More: News From December 2018

    Bio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Biogen, DDN, Qlucore, and more.

    Dec 19, 2018

  • Oak Ridge Tackles Opioids With Assistance From World’s Fastest Supercomputer

    Bio-IT World | The US Department of Energy’s Oak Ridge National Laboratory is tackling the opioid crisis by using the world’s fastest supercomputer. With the help of IBM’s recently launched Summit supercomputer, the Oak Ridge team was able to analyze 85 million genetic markers and understand  complex, epistatic genetic architectures responsible for challenging traits in phenotype.

    Dec 14, 2018

  • Allen Institute Announces New Division Dedicated To Studying Human Immune System

    Bio-IT World | The Allen Institute announced a new division, the Allen Institute for Immunology, which will be dedicated to studying the human immune system.

    Dec 13, 2018

  • Pharma’s AI Future

    Bio-IT World | The recent AI World Conference & Expo made one thing clear: now is the time for pharma to embrace AI and start realizing some of the benefits other industries are enjoying.

    Dec 12, 2018

  • Rehm Replaces Haussler As GA4GH Vice Chair, Other Changes

    Bio-IT World Brief  GA4GH announced several changes in leadership. GA4GH Vice Chair David Haussler, Scientific Director of the University of California Santa Cruz Genomics Institute, will be succeeded by Heidi Rehm,an institute member at the Broad Institute of MIT and Harvard and chief genomics officer at Massachusetts General Hospital. 

    Dec 10, 2018

  • 10x Genomics Acquires Spatial Genomics Company

    Bio-IT World Brief   10x Genomics has acquired Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. The new field enables researchers to not only see what is in a cell but how cells are organized in relation to one another, offering up invaluable insight into understanding disease.

    Dec 10, 2018

  • A Mature Capital Structure Positions Bio-IT Startups For Success

    Bio-IT World Contributed Commentary | By establishing a mature capital structure reflecting a healthy balance of both equity and debt, early-stage bio-IT companies can project long-term strength and vision that helps to favorably position them with their stakeholders.

    Dec 6, 2018

  • GSK Bags Tesaro For $5B As It Leaps Back Into Commercial Oncology, Beefs Up Cancer Drug Pipeline

    Endpoints News | GlaxoSmithKline has struck a deal to buy Tesaro in a $5.1 billion deal that will vault the pharma giant into the commercial oncology market as it stakes out a big new role for itself in the booming cancer field.

    Dec 5, 2018

  • OmniTier Debuts CompStor Novos Platform For De Novo Assembly-Based Variant Calling

    Bio-IT World News Brief | OmniTier has debuted the CompStor Novos platform for de novo assembly-based variant calling in whole genome sequencing applications.

    Dec 5, 2018